APA (7th ed.) Citation

Liu, L., Deng, Y., Li, L., Yang, X., Yin, Z., & Lai, Y. Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Liu, Lingyan, Yongkun Deng, Lei Li, Xingbiao Yang, Zhaoheng Yin, and Yong Lai. Efficacy and Safety of Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin Monotherapy in the Treatment of Composite Cardiovascular Events with Hypercholesterolemia: A Meta-analysis. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Liu, Lingyan, et al. Efficacy and Safety of Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin Monotherapy in the Treatment of Composite Cardiovascular Events with Hypercholesterolemia: A Meta-analysis. Public Library of Science (PLoS).